Smart rings are a useful sleep tool, but the published data says they are not a like-for-like replacement for a Level 3 home sleep test when the goal is an initial obstructive sleep apnea (OSA) diagnosis. Where the ring earns its place is after diagnosis: tracking whether an oral appliance is working, night after night.

Many home sleep test (HST) providers are moving from traditional Level 3 kits to ring-based testing. Rings are easier to ship, easier to wear, and patients like them. But practices we work with are seeing a pattern: patients who would likely have been diagnosed with OSA on a Level 3 test are coming back negative, or classified as less severe, on a ring. The research explains why.

💡 The Short Version

Diagnose with a Level 3 HST. Monitor with a ring. Rings perform well for moderate-to-severe OSA but have lower sensitivity for mild OSA, which is the core oral appliance population.

What the Data Shows

The consistent finding across studies: rings and other PPG-based (pulse-signal) devices do well at catching moderate-to-severe OSA and struggle with mild OSA.

  • American Academy of Sleep Medicine (2025): PPG-based HSATs show strong sensitivity for moderate-to-severe OSA, but lower sensitivity in mild and mild-to-moderate cases.
  • Systematic review and meta-analysis of finger-worn devices (2025): 11 devices across 28 studies compared against in-lab polysomnography. Effective for screening severe OSA; mild OSA detection remains a persistent challenge. The authors state results must be interpreted by intended use.
  • Belun Ring FDA clearance (K222579): one of the best-known FDA-cleared rings is cleared for diagnosing moderate to severe OSA, not mild.
  • Belun Ring validation study: at the moderate cutoff (AHI ≥ 15), 93% sensitivity and 74% specificity. Performance was reported at the moderate threshold.
  • PPG smartwatch validation study: for any OSA (AHI ≥ 5), sensitivity was 67.5%, meaning roughly one in three patients with OSA was missed. Accuracy was higher for moderate-to-severe disease.

To be fair to the technology: several rings are FDA-cleared, and for patients with moderate-to-severe disease they perform well. The problem is narrower, and it is exactly where dental sleep medicine lives.

Why Rings Miss Mild OSA

A Level 3 test measures breathing directly. A ring infers it. That difference matters most when events are subtle.

  • 1
    No airflow or effort channels

    A Level 3 device records at minimum nasal airflow, chest and abdominal effort, and oxygen saturation. Rings rely on a pulse signal, oxygen, and motion, then estimate breathing events with an algorithm.

  • 2
    Hypopneas without a big oxygen drop go uncounted

    Mild OSA is often driven by hypopneas. Current AASM scoring counts a hypopnea with a 3% desaturation or an arousal. Research on oximetry-based wearables shows AHI is likely to be underestimated when detection depends on desaturation alone.

  • 3
    Arousal-based events matter

    A 2024 analysis of 1,561 sleep studies found that indices unable to capture arousal-related hypopneas underestimate AHI, and that diagnostic accuracy drops in mild OSA.

⚠️ The Practical Risk

A patient with mild OSA on a full study can score under the diagnostic threshold on a ring and be told they don't have sleep apnea.

Why This Matters for Dental Sleep Medicine

Mild-to-moderate OSA is the core oral appliance population. The AASM/AADSM clinical practice guideline recommends oral appliances for adults with OSA who are CPAP-intolerant or prefer an alternative, and many of those patients sit at the mild end.

If the screening test under-calls mild disease, three things happen:

  • Patients who could benefit from an appliance never get a diagnosis, so there is nothing to treat.
  • Patients with symptoms (snoring, fatigue, bruxism) leave without answers.
  • Practices lose the medical necessity documentation needed to bill medical insurance for the appliance.

Coverage and Billing Considerations

From a billing standpoint, the test type has to match what the payer recognizes as diagnostic.

Medicare NCD 240.4.1: Sleep Testing for OSA
Covers Type III devices (at least 4 channels including airflow or respiratory effort), Type IV devices measuring 3 or more channels including airflow, and devices measuring actigraphy, oximetry and peripheral arterial tone.
Summary. Confirm which category a ring device claims before relying on it for a diagnostic claim.
  • Commercial payers can be stricter. Aetna's OSA policy, for example, considers studies that don't provide both an AHI and oxygen saturation not medically necessary.
  • Scoring rules differ. Medicare uses the 4% desaturation hypopnea rule, while the AASM recommends 3%. A device already prone to undercounting hypopneas is under even more pressure under the 4% rule.

As always, the ordering and interpreting physician owns the diagnostic decision. Our role is making sure the documentation that reaches the payer supports the claim.

Our Position: Diagnose with a Level 3, Monitor with a Ring

The ring's strengths (comfort, multi-night wear, easy repeat use) are exactly what treatment follow-up needs. We recommend this workflow:

  • 1
    Diagnose with a Level 3 HST

    Or PSG when indicated. Airflow and effort channels give the most reliable AHI for mild and moderate patients and the strongest documentation for medical billing.

  • 2
    Deliver and titrate the oral appliance

    Follow your standard delivery and titration protocol.

  • 3
    Use a ring for ongoing monitoring

    Multi-night ring data can show whether the trend is moving the right way during titration and between visits.

  • 4
    Confirm efficacy per the physician's order

    The AASM/AADSM guideline suggests follow-up sleep testing to improve or confirm treatment efficacy for patients fitted with oral appliances. Whether a ring satisfies that step is the sleep physician's call and the payer's rule, so verify both.

✅ One Caution

The same mild-OSA blind spot applies after treatment. A "normal" ring reading on the appliance is encouraging, but it may not rule out residual mild OSA. Position the ring as a monitoring tool alongside, not instead of, a formal efficacy study when one is required.

Key Takeaways

  • Rings perform well for moderate-to-severe OSA but have lower sensitivity for mild OSA
  • Rings infer breathing from pulse and oxygen; Level 3 tests measure airflow and effort directly
  • Mild-to-moderate OSA is the core oral appliance population, so missed mild cases hit dental sleep practices hardest
  • Confirm the device type meets Medicare NCD 240.4.1 and your commercial payers' policies before billing
  • Best fit: Level 3 HST to diagnose, ring to monitor oral appliance performance

If your practice is seeing more negative results since your HST provider switched to rings, look at the device, how it scores hypopneas, and what your payers accept. MediClaim Works helps dental practices validate their sleep testing workflow for reimbursement readiness before claims go out.

References

This article is for educational purposes and is not medical advice. Diagnostic and treatment decisions belong to the ordering and interpreting physician.